All Stories

  1. Fixed-dose ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis

    Article • PLoS Neglected Tropical Diseases, September 2025, PLOS

    Dr Alejandro J Krolewiecki

  2. Fixed-Dose Ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis

    Article • April 2025, Cold Spring Harbor Laboratory Press

    Dr Alejandro J Krolewiecki

  3. Molecular Testing of Environmental Samples as a Potential Source to Estimate Parasite Infection

    Article • Tropical Medicine and Infectious Disease, September 2024, MDPI AG

    Dr Alejandro J Krolewiecki

  4. Population Pharmacokinetics and Exposure–Response Analysis of a Fixed‐Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults

    Article • Clinical Pharmacology & Therapeutics, September 2024, Wiley

    Dr Alejandro J Krolewiecki

  5. Exploring factors associated with Trichuris trichiura infection in school children in a high-transmission setting in Kenya

    Article • IJID Regions, June 2024, Elsevier

    Dr Alejandro J Krolewiecki

  6. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

    Article • Gates Open Research, May 2022, Faculty of 1000, Ltd.

    Dr Alejandro J Krolewiecki

  7. Strongyloides stercoralis and Trypanosoma cruzi coinfections in a highly endemic area in Argentina

    Article • PLoS Neglected Tropical Diseases, February 2022, PLOS

    Dr Alejandro J Krolewiecki

  8. Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms

    Article • The Brazilian Journal of Infectious Diseases, November 2021, Elsevier

    Dr Alejandro J Krolewiecki

  9. Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients

    Article • Viruses, October 2021, MDPI AG

    Dr Alejandro J Krolewiecki, Juan Garona

  10. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

    Article • EClinicalMedicine, July 2021, Elsevier

    Dr Alejandro J Krolewiecki

  11. Clinical diagnosis of COVID-19. A multivariate logistic regression analysis of symptoms of COVID-19 at presentation

    Article • Germs, June 2021, Asociatia Pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)

    Dr Alejandro J Krolewiecki

  12. Efficacy and Safety of Albendazole and High-Dose Ivermectin Coadministration in School-Aged Children Infected With Trichuris trichiura in Honduras: A Randomized Controlled Trial

    Article • Clinical Infectious Diseases, April 2021, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki

  13. Performance evaluation of Baermann techniques: The quest for developing a microscopy reference standard for the diagnosis of Strongyloides stercoralis

    Article • PLoS Neglected Tropical Diseases, February 2021, PLOS

    Dr Alejandro J Krolewiecki

  14. Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

    Article • PLOS One, November 2020, PLOS

    Dr Alejandro J Krolewiecki

  15. Understanding the value of clinical symptoms of COVID-19. A logistic regression model

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Dr Alejandro J Krolewiecki

  16. The Strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: A systematic review

    Article • PLoS Neglected Tropical Diseases, April 2020, PLOS

    Dr Alejandro J Krolewiecki

  17. Role of DNA-detection–based tools for monitoring the soil-transmitted helminth treatment response in drug-efficacy trials

    Article • PLoS Neglected Tropical Diseases, February 2020, PLOS

    Dr Alejandro J Krolewiecki

  18. Ivermectin for the Treatment of Soil-Transmitted Helmithiases

    Article • Current Treatment Options in Infectious Diseases, July 2019, Springer Science + Business Media

    Dr Alejandro J Krolewiecki

  19. Challenges and opportunities for control and elimination of soil-transmitted helminth infection beyond 2020

    Article • PLoS Neglected Tropical Diseases, April 2019, PLOS

    Dr Alejandro J Krolewiecki

  20. Strongyloidiasis

    Article • Infectious Disease Clinics of North America, March 2019, Elsevier

    Dr Alejandro J Krolewiecki

  21. Tegumentary leishmaniasis and sand flies in a border area between Argentina and Bolivia

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, November 2018, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki

  22. Molecular Identification of Leishmania spp. DNA from Archived Giemsa-Stained Slides of Patients from Salta, Argentina

    Article • American Journal of Tropical Medicine and Hygiene, November 2018, American Society of Tropical Medicine and Hygiene

    Dr Alejandro J Krolewiecki

  23. Misconceptions and paradoxes in soil-transmitted helminthiases control as a public health problem

    Article • PLoS Neglected Tropical Diseases, September 2018, PLOS

    Dr Alejandro J Krolewiecki

  24. Toward the 2020 goal of soil-transmitted helminthiasis control and elimination

    Article • PLoS Neglected Tropical Diseases, August 2018, PLOS

    Dr Alejandro J Krolewiecki

  25. Transrenal DNA-based diagnosis of Strongyloides stercoralis (Grassi, 1879) infection: Bayesian latent class modeling of test accuracy

    Article • PLoS Neglected Tropical Diseases, June 2018, PLOS

    Dr Alejandro J Krolewiecki

  26. Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

    Article • PLoS Neglected Tropical Diseases, January 2018, PLOS

    Dr Alejandro J Krolewiecki

  27. Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers

    Article • PLoS Neglected Tropical Diseases, January 2018, PLOS

    Dr Alejandro J Krolewiecki

  28. Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study

    Article • PLoS Neglected Tropical Diseases, October 2017, PLOS

    Dr Alejandro J Krolewiecki

  29. Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina

    Article • PLoS Neglected Tropical Diseases, October 2017, PLOS

    Dr Alejandro J Krolewiecki

  30. Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis

    Article • American Journal of Tropical Medicine and Hygiene, July 2017, American Society of Tropical Medicine and Hygiene

    Dr Alejandro J Krolewiecki

  31. A novel, species-specific, real-time PCR assay for the detection of the emerging zoonotic parasite Ancylostoma ceylanicum in human stool

    Article • PLoS Neglected Tropical Diseases, July 2017, PLOS

    Dr Alejandro J Krolewiecki

  32. High prevalence of Strongyloides stercoralis in school-aged children in a rural highland of north-western Ethiopia: the role of intensive diagnostic work-up

    Article • Parasites & Vectors, December 2016, Springer Science + Business Media

    Dr Alejandro J Krolewiecki, Endalew Yizengaw Shita

  33. Diagnosis of Strongyloides stercoralis: Detection of parasite-derived DNA in urine

    Article • Acta Tropica, November 2016, Elsevier

    Dr Alejandro J Krolewiecki

  34. StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control

    Article • PLoS Neglected Tropical Diseases, September 2016, PLOS

    Dr Alejandro J Krolewiecki

  35. PHARMACOKINETICS OF BENZNIDAZOLE IN CHAGAS DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr Alejandro J Krolewiecki

  36. Spatial spread of dengue in a non-endemic tropical city in northern Argentina

    Article • Acta Tropica, June 2016, Elsevier

    Dr Alejandro J Krolewiecki

  37. Epidemiology of American Tegumentary Leishmaniasis andTrypanosoma cruziInfection in the Northwestern Argentina

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Dr Alejandro J Krolewiecki

  38. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

    Article • PLOS One, October 2015, PLOS

    Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Dr Graham A Williams

  39. Effect of Poor Access to Water and Sanitation As Risk Factors for Soil-Transmitted Helminth Infection: Selectiveness by the Infective Route

    Article • PLoS Neglected Tropical Diseases, September 2015, PLOS

    Dr Alejandro J Krolewiecki

  40. Identification of human intestinal parasites affecting an asymptomatic peri-urban Argentinian population using multi-parallel quantitative real-time polymerase chain reaction

    Article • Parasites & Vectors, July 2015, Springer Science + Business Media

    Dr Alejandro J Krolewiecki

  41. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    Article • PLoS Medicine, March 2015, PLOS

    Dr Alejandro J Krolewiecki, Dr. Vicente Soriano, Lut Lynen, Hugh Montgomery, Prof Robert Colebunders

  42. Accuracy of Five Serologic Tests for the Follow up of Strongyloides stercoralis Infection

    Article • PLoS Neglected Tropical Diseases, February 2015, PLOS

    Dr Alejandro J Krolewiecki

  43. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collabor...

    Article • Journal of the International AIDS Society, December 2014, Wiley

    Dr Alejandro J Krolewiecki

  44. The Epidemiology of Human Strongyloidiasis

    Article • Current Tropical Medicine Reports, November 2014, Springer Science + Business Media

    Dr Ruben O. Cimino, Dr Alejandro J Krolewiecki

  45. Assessment of Anthelmintic Efficacy of Mebendazole in School Children in Six Countries Where Soil-Transmitted Helminths Are Endemic

    Article • PLoS Neglected Tropical Diseases, October 2014, PLOS

    Dr Bruno Levecke, Dr Alejandro J Krolewiecki

  46. Diagnostic Accuracy of Five Serologic Tests for Strongyloides stercoralis Infection

    Article • PLoS Neglected Tropical Diseases, January 2014, PLOS

    Dr Alejandro J Krolewiecki

  47. Mini-FLOTAC, Kato-Katz and McMaster: three methods, one goal; highlights from north Argentina

    Article • Parasites & Vectors, January 2014, Springer Science + Business Media

    Dr Alejandro J Krolewiecki

  48. Performance of differentTrypanosoma cruziantigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina

    Article • Tropical Medicine & International Health, July 2013, Wiley

    Dr Alejandro J Krolewiecki

  49. A Public Health Response against Strongyloides stercoralis: Time to Look at Soil-Transmitted Helminthiasis in Full

    Article • PLoS Neglected Tropical Diseases, May 2013, PLOS

    Dr Bruno Levecke, Dr Alejandro J Krolewiecki

  50. Strongyloides stercoralis: A Plea for Action

    Article • PLoS Neglected Tropical Diseases, May 2013, PLOS

    Dr Alejandro J Krolewiecki

  51. Restricted Outbreak of American Tegumentary Leishmaniasis with High Microfocal Transmission

    Article • American Journal of Tropical Medicine and Hygiene, March 2013, American Society of Tropical Medicine and Hygiene

    Dr Alejandro J Krolewiecki

  52. Estimation of HIV-Testing Rates to Maximize Early Diagnosis-Derived Benefits at the Individual and Population Level

    Article • PLOS One, January 2013, PLOS

    Dr Alejandro J Krolewiecki

  53. A phase 4, single-arm, open-label, pilot study of maraviroc, raltegravir and darunavir/r in HIV-1 adults with triple class failure: TERCETO study

    Article • Journal of the International AIDS Society, November 2012, Wiley

    Dr Alejandro J Krolewiecki

  54. Development of a new platform for neglected tropical disease surveillance

    Article • International Journal for Parasitology, August 2012, Elsevier

    Dr Alejandro J Krolewiecki

  55. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

    Article • Journal of Antimicrobial Chemotherapy, April 2012, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki, Dr. Vicente Soriano

  56. Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification

    Article • PLoS Medicine, April 2012, PLOS

    Dr Alejandro J Krolewiecki

  57. No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30days course of nitazoxanide monotherapy

    Article • Antiviral Research, December 2011, Elsevier

    Dr Alejandro J Krolewiecki, Dr Jorge F Quarleri

  58. Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen

    Article • PLOS One, August 2011, PLOS

    Dr Alejandro J Krolewiecki

  59. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies

    Article • Parasitology, April 2011, Cambridge University Press

    Dr Alejandro J Krolewiecki

  60. Cancer in HIV-Infected Persons From the Caribbean, Central and South America

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

    Dr Alejandro J Krolewiecki

  61. Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters

    Article • Journal of the International AIDS Society, January 2011, Wiley

    Dr Alejandro J Krolewiecki

  62. Improved Diagnosis of Strongyloides stercoralis Using Recombinant Antigen-Based Serologies in a Community-Wide Study in Northern Argentina

    Article • Clinical and Vaccine Immunology, August 2010, ASM Journals

    Dr Alejandro J Krolewiecki

  63. Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America

    Article • PLOS One, June 2010, PLOS

    Dr Alejandro J Krolewiecki

  64. Urban Transmission of American Cutaneous Leishmaniasis in Argentina: Spatial Analysis Study

    Article • American Journal of Tropical Medicine and Hygiene, March 2010, American Society of Tropical Medicine and Hygiene

    Dr Alejandro J Krolewiecki

  65. Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2009, Wolters Kluwer Health

    Dr Alejandro J Krolewiecki

  66. Use of darunavir and enfuvirtide in a pregnant woman

    Article • International Journal of STD & AIDS, December 2008, SAGE Publications

    Dr Alejandro J Krolewiecki

  67. Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy

    Article • Annals of Internal Medicine, September 2008, American College of Physicians

    Dr Alejandro J Krolewiecki

  68. Inferior Clinical Outcome of the CD4+Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+Cell Counts and HIV RNA Levels during Follow‐up

    Article • The Journal of Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki

  69. Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study

    Article • The Journal of Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki

  70. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model

    Article • Revista da Sociedade Brasileira de Medicina Tropical, December 2007, FapUNIFESP (SciELO)

    Dr Alejandro J Krolewiecki

  71. Safe Treatment Interruptions in Patients With Nadir CD4 Counts of More Than 350 Cells/??L

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2006, Wolters Kluwer Health

    Dr Alejandro J Krolewiecki

  72. Human Immunoglobulin G Mediates Protective Immunity and Identifies Protective Antigens against LarvalStrongyloides stercoralisin Mice

    Article • The Journal of Infectious Diseases, April 2004, Oxford University Press (OUP)

    Dr Alejandro J Krolewiecki

  73. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis

    Article • Revista da Sociedade Brasileira de Medicina Tropical, January 2003, FapUNIFESP (SciELO)

    Dr Alejandro J Krolewiecki

  74. Activity of azithromycin against Leishmania major in vitro and in vivo.

    Article • American Journal of Tropical Medicine and Hygiene, September 2002, American Society of Tropical Medicine and Hygiene

    Dr Alejandro J Krolewiecki

  75. Effect of Chronic Ethanol Consumption on Protective T-Helper 1 and T-Helper 2 Immune Responses Against the Parasites Leishmania major and Strongyloides stercoralis in Mice

    Article • Alcoholism Clinical and Experimental Research, April 2001, Wiley

    Dr Alejandro J Krolewiecki

  76. Effect of Chronic Ethanol Consumption on Protective T-Helper 1 and T-Helper 2 Immune Responses Against the Parasites Leishmania major and Strongyloides stercoralis in Mice

    Article • Alcoholism Clinical and Experimental Research, April 2001, Wiley

    Dr Alejandro J Krolewiecki

  77. Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individuals

    Article • AIDS, September 2000, Wolters Kluwer Health

    Dr Alejandro J Krolewiecki

  78. More on Continuous-Infusion Acyclovir for Severe Varicella

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 1997, New England Journal of Medicine (NEJM/MMS)

    Dr Alejandro J Krolewiecki